Personalized vaccine reduces melanoma recurrence in trial

Orbit summarizes health news from several newsrooms. It is not medical advice. Talk to a doctor or pharmacist about your own health.

At a glance

Clinical trial results show a personalized vaccine lowers the risk of cancer recurrence.2 3
The study examined a vaccine designed to prevent melanoma from returning in patients.1 3
Scientists say the trial marks progress toward tailored, personalized cancer treatments.2 3

Researchers found in a clinical trial that a personalized vaccine reduces the risk of cancer recurrence.2 3

The tested vaccine specifically targets melanoma to prevent the disease from returning.1 3

Scientists noted that these results advance personalized medicine by offering tailored approaches to cancer care.2 3

Where sources agree

Personalized vaccine reduces cancer recurrence risk2 of 3
Clinical trial tested a melanoma vaccine2 of 3
Results advance personalized cancer care2 of 3

Who covered this

1 National2 International

Sources

Based on reporting from these reputable newsrooms and reviewed by Orbit’s editors. A fact appears only when at least two sources report it. Orbit is not affiliated with these publishers.

Report an error How we source